Article By:
TipRanks
Sunday, April 5, 2015 1:27 PM EDT
As the biotech sector becomes more volatile, analyst Joseph Pantginis of Roth Capital points out that it is increasingly necessary to “focus on names with definitive catalysts.” Though the analyst rates 15 biotech stocks, we have highlighted 5 of them.